Terms: = Bone cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Clinical Outcome
4 results:
1. Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival.
Kanda S; Tsuchiya N; Narita S; Inoue T; Huang M; Chiba S; Akihama S; Saito M; Numakura K; Tsuruta H; Satoh S; Saito S; Ohyama C; Arai Y; Ogawa O; Habuchi T
Int J Cancer; 2015 Jan; 136(1):74-82. PubMed ID: 24803183
[TBL] [Abstract] [Full Text] [Related]
2. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
[TBL] [Abstract] [Full Text] [Related]
3. Minimal residual disease in early phase of chemotherapy reflects poor outcome in children with acute lymphoblastic leukemia--a retrospective study by the Children's cancer and Leukemia Study Group in Japan.
Okamoto T; Yokota S; Katano N; Seriu T; Nakao M; Taniwaki M; Watanabe A; Asami K; Kikuta A; Koizumi S; Kawakami T; Ohta S; Miyake M; Watanabe T; Iwai A; Kamitamari A; Ijichi O; Hyakuna N; Mimaya J; Fujimoto T; Tsurusawa M
Leuk Lymphoma; 2002 May; 43(5):1001-6. PubMed ID: 12148878
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET.
Eschmann SM; Reischl G; Bilger K; Kupferschläger J; Thelen MH; Dohmen BM; Besenfelder H; Bares R
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):760-7. PubMed ID: 12029549
[TBL] [Abstract] [Full Text] [Related]
